Adding tafasitamab to treatment with lenalidomide and rituximab improved outcomes in patients with relapsed or refractory follicular lymphoma.

The FDA has approved tafasitamab in combination with lenalidomide and rituximab for adults with relapsed/refractory ...

Adding polatuzumab vedotin (Polivy) to standard-of-care treatment significantly improved overall survival (OS) in patients ...

Sobi® (STO: SOBI) will present data at the 30th EHA (European Haematology Association) hybrid congress, in Milan, Italy (12-15 June). The congress will ...

Cytokines ITP is an autoimmune disease ... your doctor may prescribe an intravenous therapy of rituximab (Rituxan) — a monoclonal antibody that stops the destruction of platelets — or an ...

A combined treatment approach using romiplostim, low-dose rituximab, and high-dose dexamethasone in patients with newly diagnosed immune thrombocytopenia (ITP) has shown promising results, according ...

Initially presenting with dizziness and weakness, her condition progressed to include thrombocytopenia ... plasma exchange, and rituximab, with a gradual return to normal values for ADAMTS13 ...

A 2022 study also indicates that race affects overall relapse risk and response to rituximab, a medication doctors may use off label to treat thrombocytopenia. The researchers suggest state that ...

Despite preliminary, orelabrutinib+rituximab achieved high adaptability ... clinical trials for the treatment of SLE, Primary Immune Thrombocytopenia (ITP) achieved proof of concept (PoC), and ...

A recent study published in Authorea suggests that combination therapy of rituximab and daratumumab might be a promising therapeutic option for refractory post-transplant immune-mediated cytopenias ...